Treatment of Diabetes in Older Adults: An Endocrine Society

Derek Leroith, Geert Jan Biessels, Susan S. Braithwaite, Felipe F. Casanueva, Boris Draznin, Jeffrey B. Halter, Irl B. Hirsch, Marie E. Mcdonnell, Mark E. Molitch, M. Hassan Murad, Alan J. Sinclair

Research output: Contribution to journalArticlepeer-review

89 Scopus citations


Objective: The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. Conclusions: Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.

Original languageEnglish (US)
Pages (from-to)1520-1574
Number of pages55
JournalJournal of Clinical Endocrinology and Metabolism
Issue number5
StatePublished - 2019

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'Treatment of Diabetes in Older Adults: An Endocrine Society'. Together they form a unique fingerprint.

Cite this